Infliximab is a monoclonal antibody used primarily as an anti-inflammatory agent. It targets and neutralizes tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in systemic inflammation. Infliximab is commonly used in the treatment of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.
